ARA-290 is a synthetic peptide consisting of 11 amino acids,
derived from erythropoietin (EPO). Within research contexts, this molecule
is known for its interactions with tissue-protective and inflammation-related pathways.
ARA-290 is studied in scientific settings for its potential
interactions with EPOR/CD131 receptor complexes and
cellular signaling mechanisms involved in
inflammation regulation and tissue protection.
The peptide is studied within models related to neuro- and immune-related processes.
Research Relevance
- Investigated within models related to inflammation regulation.
- Relevance within studies on tissue protection.
- Studied in relation to neuro- and immune-related processes.
- Applied in experimental research setups related to cellular stress response.
Key Specifications
| Attribute | Value / Description |
|---|---|
| Peptide type | EPO-derived peptide (ARA-290) |
| Number of amino acids | 11 |
| Tested for | Purity, endotoxins and heavy metals |
| Form | Lyophilized (lyophilisate, dry powder) |
| Storage & shelf life | Lyophilized shelf life 2 years. Batch: PK-RG-009 Best before: February 4, 2028 |
Lab Results
| Status | Lab Report (COA) |
|---|---|
| ARA-290 | Under analysis |
Specifications
| Concentration (mg) | |
| Bacteriostatic Water | 3ml (included as standard), 10ml |
| Insulin Needles | 10x 0.5ml insulin needle, 10x 1ml insulin needles, None |
| Alcohol Swabs | Yes, No |
Reviews
There are no reviews yet.